Deregulated Gab2 phosphorylation mediates aberrant AKT and STAT3 signaling upon PIK3R1 loss in ovarian cancer

Xinran Li, Victor C.Y. Mak, Yuan Zhou, Chao Wang, Esther S.Y. Wong, Rakesh Sharma, Yiling Lu, Annie N.Y. Cheung, Gordon Mills, Lydia W.T. Cheung

    Research output: Contribution to journalArticle

    Abstract

    Copy number loss of PIK3R1 (p85α) most commonly occurs in ovarian cancer among all cancer types. Here we report that ovarian cancer cells manifest a spectrum of tumorigenic phenotypes upon knockdown of PIK3R1. PIK3R1 loss activates AKT and p110-independent JAK2/STAT3 signaling through inducing changes in the phosphorylation of the docking protein Gab2, thereby relieving the negative inhibition on AKT and promoting the assembly of JAK2/STAT3 signalosome, respectively. Additional mechanisms leading to AKT activation include enhanced p110α kinase activity and a decrease in PTEN level. PIK3R1 loss renders ovarian cancer cells vulnerable to inhibition of AKT or JAK2/STAT3. The combination of AKT and STAT3 inhibitors significantly increases the anti-tumor effect compared to single-agent treatments. Together, our findings provide a rationale for mechanism-based therapeutic approach that targets tumors with loss of PIK3R1.

    Original languageEnglish (US)
    Article number716
    JournalNature communications
    Volume10
    Issue number1
    DOIs
    StatePublished - Dec 1 2019

    Fingerprint

    phosphorylation
    Phosphorylation
    Ovarian Neoplasms
    cancer
    Tumors
    Neoplasms
    tumors
    Cells
    relieving
    phenotype
    Phosphotransferases
    inhibitors
    Phenotype
    assembly
    Chemical activation
    activation
    proteins
    Proteins
    Therapeutics

    ASJC Scopus subject areas

    • Chemistry(all)
    • Biochemistry, Genetics and Molecular Biology(all)
    • Physics and Astronomy(all)

    Cite this

    Li, X., Mak, V. C. Y., Zhou, Y., Wang, C., Wong, E. S. Y., Sharma, R., ... Cheung, L. W. T. (2019). Deregulated Gab2 phosphorylation mediates aberrant AKT and STAT3 signaling upon PIK3R1 loss in ovarian cancer. Nature communications, 10(1), [716]. https://doi.org/10.1038/s41467-019-08574-7

    Deregulated Gab2 phosphorylation mediates aberrant AKT and STAT3 signaling upon PIK3R1 loss in ovarian cancer. / Li, Xinran; Mak, Victor C.Y.; Zhou, Yuan; Wang, Chao; Wong, Esther S.Y.; Sharma, Rakesh; Lu, Yiling; Cheung, Annie N.Y.; Mills, Gordon; Cheung, Lydia W.T.

    In: Nature communications, Vol. 10, No. 1, 716, 01.12.2019.

    Research output: Contribution to journalArticle

    Li, X, Mak, VCY, Zhou, Y, Wang, C, Wong, ESY, Sharma, R, Lu, Y, Cheung, ANY, Mills, G & Cheung, LWT 2019, 'Deregulated Gab2 phosphorylation mediates aberrant AKT and STAT3 signaling upon PIK3R1 loss in ovarian cancer', Nature communications, vol. 10, no. 1, 716. https://doi.org/10.1038/s41467-019-08574-7
    Li, Xinran ; Mak, Victor C.Y. ; Zhou, Yuan ; Wang, Chao ; Wong, Esther S.Y. ; Sharma, Rakesh ; Lu, Yiling ; Cheung, Annie N.Y. ; Mills, Gordon ; Cheung, Lydia W.T. / Deregulated Gab2 phosphorylation mediates aberrant AKT and STAT3 signaling upon PIK3R1 loss in ovarian cancer. In: Nature communications. 2019 ; Vol. 10, No. 1.
    @article{45a4529f6da9406c873cf02d6899cf5f,
    title = "Deregulated Gab2 phosphorylation mediates aberrant AKT and STAT3 signaling upon PIK3R1 loss in ovarian cancer",
    abstract = "Copy number loss of PIK3R1 (p85α) most commonly occurs in ovarian cancer among all cancer types. Here we report that ovarian cancer cells manifest a spectrum of tumorigenic phenotypes upon knockdown of PIK3R1. PIK3R1 loss activates AKT and p110-independent JAK2/STAT3 signaling through inducing changes in the phosphorylation of the docking protein Gab2, thereby relieving the negative inhibition on AKT and promoting the assembly of JAK2/STAT3 signalosome, respectively. Additional mechanisms leading to AKT activation include enhanced p110α kinase activity and a decrease in PTEN level. PIK3R1 loss renders ovarian cancer cells vulnerable to inhibition of AKT or JAK2/STAT3. The combination of AKT and STAT3 inhibitors significantly increases the anti-tumor effect compared to single-agent treatments. Together, our findings provide a rationale for mechanism-based therapeutic approach that targets tumors with loss of PIK3R1.",
    author = "Xinran Li and Mak, {Victor C.Y.} and Yuan Zhou and Chao Wang and Wong, {Esther S.Y.} and Rakesh Sharma and Yiling Lu and Cheung, {Annie N.Y.} and Gordon Mills and Cheung, {Lydia W.T.}",
    year = "2019",
    month = "12",
    day = "1",
    doi = "10.1038/s41467-019-08574-7",
    language = "English (US)",
    volume = "10",
    journal = "Nature Communications",
    issn = "2041-1723",
    publisher = "Nature Publishing Group",
    number = "1",

    }

    TY - JOUR

    T1 - Deregulated Gab2 phosphorylation mediates aberrant AKT and STAT3 signaling upon PIK3R1 loss in ovarian cancer

    AU - Li, Xinran

    AU - Mak, Victor C.Y.

    AU - Zhou, Yuan

    AU - Wang, Chao

    AU - Wong, Esther S.Y.

    AU - Sharma, Rakesh

    AU - Lu, Yiling

    AU - Cheung, Annie N.Y.

    AU - Mills, Gordon

    AU - Cheung, Lydia W.T.

    PY - 2019/12/1

    Y1 - 2019/12/1

    N2 - Copy number loss of PIK3R1 (p85α) most commonly occurs in ovarian cancer among all cancer types. Here we report that ovarian cancer cells manifest a spectrum of tumorigenic phenotypes upon knockdown of PIK3R1. PIK3R1 loss activates AKT and p110-independent JAK2/STAT3 signaling through inducing changes in the phosphorylation of the docking protein Gab2, thereby relieving the negative inhibition on AKT and promoting the assembly of JAK2/STAT3 signalosome, respectively. Additional mechanisms leading to AKT activation include enhanced p110α kinase activity and a decrease in PTEN level. PIK3R1 loss renders ovarian cancer cells vulnerable to inhibition of AKT or JAK2/STAT3. The combination of AKT and STAT3 inhibitors significantly increases the anti-tumor effect compared to single-agent treatments. Together, our findings provide a rationale for mechanism-based therapeutic approach that targets tumors with loss of PIK3R1.

    AB - Copy number loss of PIK3R1 (p85α) most commonly occurs in ovarian cancer among all cancer types. Here we report that ovarian cancer cells manifest a spectrum of tumorigenic phenotypes upon knockdown of PIK3R1. PIK3R1 loss activates AKT and p110-independent JAK2/STAT3 signaling through inducing changes in the phosphorylation of the docking protein Gab2, thereby relieving the negative inhibition on AKT and promoting the assembly of JAK2/STAT3 signalosome, respectively. Additional mechanisms leading to AKT activation include enhanced p110α kinase activity and a decrease in PTEN level. PIK3R1 loss renders ovarian cancer cells vulnerable to inhibition of AKT or JAK2/STAT3. The combination of AKT and STAT3 inhibitors significantly increases the anti-tumor effect compared to single-agent treatments. Together, our findings provide a rationale for mechanism-based therapeutic approach that targets tumors with loss of PIK3R1.

    UR - http://www.scopus.com/inward/record.url?scp=85061500872&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85061500872&partnerID=8YFLogxK

    U2 - 10.1038/s41467-019-08574-7

    DO - 10.1038/s41467-019-08574-7

    M3 - Article

    VL - 10

    JO - Nature Communications

    JF - Nature Communications

    SN - 2041-1723

    IS - 1

    M1 - 716

    ER -